Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
141.40
+2.47 (1.78%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Repligen Market Cap

Repligen has a market cap or net worth of $7.94 billion as of April 24, 2025. Its market cap has decreased by -18.05% in one year.

Market Cap
7.94B
Enterprise Value
7.87B
1-Year Change
-18.05%
Ranking
Category
Stock Price
$141.40

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $7.94B, an increase of 28,169.50%. That is a compound annual growth rate of 23.83%.

History

DateMarket Cap% Change
Apr 22, 20257.80B-3.27%
Dec 31, 20248.06B-19.67%
Dec 29, 202310.04B6.78%
Dec 30, 20229.40B-35.80%
Dec 31, 202114.64B45.21%
Dec 31, 202010.08B109.40%
Dec 31, 20194.82B108.18%
Dec 31, 20182.31B46.35%
Dec 29, 20171.58B51.58%
Dec 30, 20161.04B11.88%
Dec 31, 2015932.00M43.85%
Dec 31, 2014647.90M48.87%
Dec 31, 2013435.20M122.72%
Dec 31, 2012195.40M83.30%
Dec 30, 2011106.60M-26.18%
Dec 31, 2010144.40M14.24%
Dec 31, 2009126.40M7.21%
Dec 31, 2008117.90M-41.78%
Dec 31, 2007202.50M137.12%
Dec 29, 200685.40M-29.07%
Dec 30, 2005120.40M39.03%
Dec 31, 200486.60M-33.64%
Dec 31, 2003130.50M57.04%
Dec 31, 200283.10M28.04%
Dec 31, 200164.90M-27.65%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 754.27B
UnitedHealth Group 415.38B
Johnson & Johnson 379.48B
AbbVie 306.02B
Novo Nordisk 284.50B
Abbott Laboratories 227.16B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings